Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
70 studies found for:    Polymyositis
Show Display Options
Rank Status Study
21 Recruiting A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
Condition: Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
Interventions: Biological: MEDI7734;   Biological: Placebo
22 Completed myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
Conditions: Polymyositis;   Dermatomyositis
Interventions: Other: transcriptome analysis;   Other: T cell repertoire analysis
23 Completed Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
Conditions: Dermatomyositis;   Inclusion Body Myositis;   Polymyositis
Intervention: Drug: Gamma Globulin
24 Completed Epidemiological Study of Inflammatory Myopathies in a French Region
Condition: Polymyositis
Intervention:
25 Completed Anakinra in Myositis
Conditions: Polymyositis;   Dermatomyositis;   Inclusion Body Myositis
Intervention: Drug: Anakinra
26 Completed Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients
Conditions: Myositis;   Exercise
Intervention: Other: exercise
27 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Inclusion Body Myositis
Intervention:
28 Not yet recruiting Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Conditions: Polymyositis;   Dermatomyositis
Interventions: Drug: Abatacept;   Drug: Placebo
29 Completed Treatment With TNF Blockade, Infliximab, in Patients With Myositis
Condition: Refractory Myositis
Intervention: Drug: Infliximab
30 Recruiting Environmental Risk Factors for Myositis in Military Personnel
Conditions: Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   Myositis
Intervention:
31 Unknown  Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia
Condition: Pompe Disease
Intervention:
32 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
33 Completed
Has Results
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Sifalimumab
34 Unknown  Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits
35 Active, not recruiting Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Conditions: Myositis;   Polymyositis;   Dermatomyositis;   Myositis, Inclusion Body
Intervention: Procedure: MRI-oriented muscle biopsy
36 Completed Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
Conditions: Otorhinolaryngologic Disease;   Otorhinolaryngologic Neoplasm;   Pharyngeal Neoplasm;   Polymyositis;   Speech Disorder
Intervention:
37 Completed Mycophenolate Mofetil in Systemic Sclerosis
Condition: Diffuse Cutaneous Systemic Sclerosis
Intervention: Drug: Mycophenolate Mofetil
38 Unknown  A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
Condition: Idiopathic Inflammatory Myopathy
Intervention:
39 Recruiting Pulmonary Fibrosis Contact Registry
Conditions: Pulmonary Fibrosis of Any Cause;   Primary Supporters/Caretakers of Patients With Pulmonary Fibrosis
Intervention:
40 Completed Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
Conditions: Rheumatoid Arthritis;   Polymyalgia Rheumatica;   Giant Cell Arteritis;   Polymyositis;   Wegener’s Granulomatosis
Intervention: Drug: Alendronate versus alfacalcidol (1-alpha OH vitamin D)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.